Brief: Weight Watchers Expands Med+ With Access To New Ozempic® Pill (Semaglutide)
01/05/2026 14:24
May 1 (Reuters) - WW International Inc WW.O: WEIGHT WATCHERS EXPANDS MED+ WITH ACCESS TO NEW OZEMPIC® PILL (SEMAGLUTIDE) WW INTERNATIONAL INC - OZEMPIC MONTHLY PRESCRIPTION COSTS AS LOW AS $25 FOR ELIGIBLE MEMBERS Source text: ID:nGNXc68SQv Further company coverage: WW.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on WW International
See all newsWeight Watchers tumbles as investors say hello to Bye
Weight Watchers names Stephen Bye as CEO
WW International Inc reports results for the quarter ended June 30 - Earnings Summary
WW International Q2 revenue beats estimates on Clinical growth
WW International Inc expected to post earnings of 24 cents a share - Earnings Preview